ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Chronic Obstructive Pulmonary Disease
Nasal Polyps
Respiratory Tract Diseases
Rhinosinusitis

Asthma trials near Paris, Île-de-France, FRA:

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma. (ARRIVAL)

administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...

Enrolling
Severe Asthma
Combination Product: Budesonide/formoterol
Combination Product: Mannitol

Phase 3

AstraZeneca
AstraZeneca

Créteil, France and 84 other locations

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Paris, France and 86 other locations

is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...

Enrolling
Asthma
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Paris, France and 260 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Paris, France and 140 other locations

The main objective of this study is to evaluate efficacy and safety of patient's learning in self-taking of prescribed asthma maintenance tr...

Active, not recruiting
Asthma in Children
Device: JOE
Ludocare

Paris, France and 12 other locations

This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...

Enrolling
Eosinophilic Asthma
Combination Product: Placebo for Benralizumab
Combination Product: benralizumab

Phase 3

AstraZeneca
AstraZeneca

Suresnes, France and 139 other locations

Locations recently updated

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Enrolling
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Paris, France and 73 other locations

levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...

Enrolling
Asthma
Drug: Brenipatide
Drug: Placebo

Phase 2

Lilly
Lilly

Paris, France and 114 other locations

administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled c...

Enrolling
Asthma
Device: Inhaler
Drug: AZD8630

Phase 2

AstraZeneca
AstraZeneca

Paris, France and 231 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Enrolling
Asthma
Drug: Short-Acting Beta Agonists (SABA)
Drug: Fluticasone/salmeterol

Phase 2

Sanofi
Sanofi

Paris, France and 228 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems